missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ro 6842262, >98%, Tocris Bioscience™
Click to view available options
Quantity:
10 mg
50 mg
Description
Potent LPA1 antagonist (IC50 = 25 nM). Exhibits >1,200-fold selectivity for LPA1 over LPA3. Attenuates NHLF human lung fibroblast cell proliferation and contraction in vitro. Also reduces plasma histamine levels in mouse LPA-challenge model. Orally bioavailable.
Specifications
Specifications
Linear Formula | C28H26N4O4 |
Solubility Information | Soluble to 100mM in DMSO and to 20mM in ethanol |
Quantity | 10 mg |
Formula Weight | 482.53 |
Chemical Name or Material | 1-[4′-[4-Methyl-5-[[[(1R)-1-phenylethoxy]carbonylamino]-1H-1,2,3-triazol-1-yl][1,1′-biph |
Grade | >98% |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction